Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases
- PMID: 27486570
- PMCID: PMC4958366
- DOI: 10.2147/RRU.S109319
Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases
Abstract
Peyronie's disease (PD) is a chronic inflammatory disease involving the tunica albuginea of the penis. Erectile dysfunction (ED) is a possible invalidating symptom of PD. The aim of this study was to evaluate the prevalence, psychological impact, and risk factors of ED in patients with PD. The study was conducted by carrying out a retrospective analysis of the clinical records of 309 patients with PD who visited our andrology clinic. All patients underwent the following tests: body mass index, common blood tests and hormone assays, questionnaire for erectile function assessment, dynamic penile color Doppler ultrasonography, imaging of the penis at maximum erection with photographic poses according to Kelâmi, psychosexual impact evaluation with PD Questionnaire (symptom bother score), evaluation of depression symptoms with the Patient Health Questionnaire-9, and evaluation of the intensity of penile pain with the pain intensity numeric rating scale. ED was observed in 37.5% of the cases. We divided the cases into two groups: group A (PD + ED), 116 cases, and group B (PD without ED), 193 cases. After multivariate analysis, we concluded that the following comorbidities are independent risk factors for ED: dyslipidemia, obesity, chronic prostatitis, benign prostatic hyperplasia, and autoimmune diseases. A depressive disorder was observed in 62.4%, and it was more frequent in patients with PD + ED (91.37% versus 45.07% group B). Sexual bother was greater in group A compared with group B (9.7 versus 7.6). Intensities of depressive symptoms and sexual bother were significantly higher compared with cases with no curvature when the bend angle was ≥30°. Our study confirms that an integrated psychological support with medical treatment is needed in patients with PD.
Keywords: Peyronie’s disease; erectile dysfunction; psychological distress; psychosocial impact; risk factors.
Similar articles
-
Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases.Diagnostics (Basel). 2024 May 29;14(11):1125. doi: 10.3390/diagnostics14111125. Diagnostics (Basel). 2024. PMID: 38893650 Free PMC article.
-
Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire.J Urol. 2013 Aug;190(2):627-34. doi: 10.1016/j.juro.2013.01.090. Epub 2013 Jan 31. J Urol. 2013. PMID: 23376705
-
Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction.BJU Int. 2012 Oct;110(8):1201-5. doi: 10.1111/j.1464-410X.2011.10851.x. Epub 2012 Feb 7. BJU Int. 2012. PMID: 22313546
-
Review of Management Options for Patients With Atypical Peyronie's Disease.Sex Med Rev. 2017 Apr;5(2):211-221. doi: 10.1016/j.sxmr.2016.07.004. Epub 2016 Aug 17. Sex Med Rev. 2017. PMID: 27544298 Review.
-
Shockwave Therapy in the Treatment of Peyronie's Disease.Sex Med Rev. 2019 Jul;7(3):499-507. doi: 10.1016/j.sxmr.2019.02.001. Epub 2019 Mar 26. Sex Med Rev. 2019. PMID: 30926460 Review.
Cited by
-
Management of residual penile curvature after penile prosthesis placement.Asian J Androl. 2021 Mar-Apr;23(2):129-134. doi: 10.4103/aja.aja_62_20. Asian J Androl. 2021. PMID: 33106463 Free PMC article. Review.
-
Development of a new Peyronie's disease self-assessment screening app.Transl Androl Urol. 2024 Nov 30;13(11):2617-2624. doi: 10.21037/tau-24-273. Epub 2024 Nov 28. Transl Androl Urol. 2024. PMID: 39698562 Free PMC article. Review.
-
Peyronie's disease: is it genetic or not?Transl Androl Urol. 2020 Mar;9(Suppl 2):S262-S268. doi: 10.21037/tau.2019.10.21. Transl Androl Urol. 2020. PMID: 32257867 Free PMC article. Review.
-
The extra-tunical grafting procedure for Peyronie's disease hourglass and indent deformities.Transl Androl Urol. 2018 Mar;7(Suppl 1):S1-S6. doi: 10.21037/tau.2017.12.03. Transl Androl Urol. 2018. PMID: 29644164 Free PMC article.
-
Ultrasound Elastography as a Diagnostic Tool for Peyronie's Disease: A State-of-the-Art Review.Diagnostics (Basel). 2024 Mar 21;14(6):665. doi: 10.3390/diagnostics14060665. Diagnostics (Basel). 2024. PMID: 38535085 Free PMC article. Review.
References
-
- Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88(7):727–730. - PubMed
-
- Mulhall JP, Creech SD, Boorjian SA, et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171(6 pt 1):2350–2353. - PubMed
-
- Diegelmann RF. Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J Urol. 1997;157(1):298–302. - PubMed
-
- Somers KD, Dawson DM. Fibrin deposition in Peyronie’s disease plaque. J Urol. 1997;157(1):311–315. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources